Business
Daily Coverage on Healthcare Stocks: BELLUS Health, Helius Medical Technologies, Resverlogix, and Crescita Therapeutics
LONDON, UK / ACCESSWIRE / July 5, 2017 / Pro-Trader Daily has lined up these stocks for our ...
About this update from Resverlogix Corp.
[{"type":"text","content":"Daily Coverage on Healthcare Stocks: BELLUS Health, Helius Medical Technologies, Resverlogix, and Crescita TherapeuticsLONDON, UK / ACCESSWIRE / July 5, 2017 / Pro-Trader Daily has lined up these stocks for our daily research reports coverage. Before the markets open, Pro-TD makes a brief technical snapshot of select stocks with the Biotechnology industry and that trades on the Toronto Exchanges. This Morning, our team has regrouped these stocks for study: BELLUS Health, Helius Medical Technologies, Resverlogix, and Crescita Therapeutics. Register for these free reports at:\n \nhttp://protraderdaily.com/register/\n \nOn Tuesday, July 04, 2017, the Toronto Exchange Composite Index was down 0.34%, finishing the day at 15,130.61.\n \nAdditionally, the Healthcare index was slightly down by 0.79%, ending the session at 70.38.\n \nPro-Trader Daily's complimentary research reports on the following stocks are now available: BELLUS Health Inc. (TSX: BLU), Helius Medical Technologies Inc. (TSX: HSM), Resverlogix Corporation (TSX: RVX), and Crescita Therapeutics Inc. (TSX: CTX). Sign up now for your free membership and research reports at:\n \nhttp://protraderdaily.com/register/\n \nBELLUS Health Inc.\n \nLaval, Canada-based BELLUS Health Inc.'s stock finished Tuesday's session flat at $0.45 with a total volume of 20,117 shares traded. Over the last one month and the previous three months, BELLUS Health's shares have gained 3.49% and 64.81%, respectively. Furthermore, the stock has surged 48.33% in the past one year. Shares of the Company, which engages in developing novel therapeutics for conditions with high unmet medical need, are trading above its 50-day and 200-day moving averages. BELLUS Health's 50-day moving average of $0.39 is above its 200-day moving average of $0.31. See our research report on BLU.TO at:\n \nhttp://protraderdaily.com/optin/?symbol=BLU \nHelius Medical Technologies Inc.\n \nOn Tuesday, shares in Newtown, Pennsylvania headquartered Helius Medical Technologies Inc. recorded a trading volume of 9,085 shares. The stock ended the day 0.50% lower at $2.00. Helius Medical Technologies' stock has surged 43.57% in the previous one year. Shares of the Company, which focuses on the development of products for the treatment of neurological symptoms caused by disease or trauma in the US, are trading below its 50-day and 200-d...